A Nutraceutical Mechanistic Model Receives a Gut Check.
作者信息
Hand Nicholas J
机构信息
Department of Genetics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Cell Mol Gastroenterol Hepatol. 2024;17(5):881-882. doi: 10.1016/j.jcmgh.2024.02.007. Epub 2024 Feb 24.
Abstract
摘要
相似文献
1
A Nutraceutical Mechanistic Model Receives a Gut Check.一种营养保健品作用机制模型接受检验。
Cell Mol Gastroenterol Hepatol. 2024;17(5):881-882. doi: 10.1016/j.jcmgh.2024.02.007. Epub 2024 Feb 24.
2
Nutraceutical regulations: An opportunity in ASEAN countries.营养保健品法规：东盟国家的一个机遇。
Nutrition. 2020 Jun;74:110729. doi: 10.1016/j.nut.2020.110729. Epub 2020 Jan 18.
3
Plant-Based Nutraceutical Formulation Modulates the Human Gut Microbiota and Ferulic Acid Esterase Activity During In Vitro Fermentation.植物源营养配方通过体外发酵调节人体肠道微生物群和阿魏酸酯酶活性。
Curr Microbiol. 2023 Nov 8;81(1):3. doi: 10.1007/s00284-023-03518-3.
4
Nutraceutical intervention protects against bacterial and chemical-induced gastrotoxicity in a non-mammalian model, Galleria mellonella.营养干预可预防非哺乳动物模型（家蚕）中的细菌和化学诱导的胃肠毒性。
Food Chem Toxicol. 2021 Aug;154:112354. doi: 10.1016/j.fct.2021.112354. Epub 2021 Jun 17.
5
Rapid Automated System for the Detection of Objectionable Microorganisms in Nutraceutical and Dietary Supplements.快速自动化系统，用于检测营养保健品和膳食补充剂中的有害微生物。
J AOAC Int. 2020 Jan 1;103(1):272-277. doi: 10.5740/jaoacint.19-0082.
6
Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards nutraceuticals: A hospital based cross-sectional study in Kavrepalanchok, Nepal.评价处方营养补充剂、其相关费用以及患者对营养保健品的知识、态度和实践：尼泊尔卡瓦普巴兰乔克的一项基于医院的横断面研究。
PLoS One. 2021 Jun 4;16(6):e0252538. doi: 10.1371/journal.pone.0252538. eCollection 2021.
7
Nutraceutical--definition and introduction.营养保健品——定义与介绍。
AAPS PharmSci. 2003;5(3):E25. doi: 10.1208/ps050325.
8
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review.新兴营养干预对多发性硬化症临床和生物学结局的影响：系统评价。
Mult Scler Relat Disord. 2020 Jan;37:101486. doi: 10.1016/j.msard.2019.101486. Epub 2019 Nov 2.
9
Anthocyanins as Immunomodulatory Dietary Supplements: A Nutraceutical Perspective and Micro-/Nano-Strategies for Enhanced Bioavailability.花色苷作为免疫调节膳食补充剂：营养保健品视角及增强生物利用度的微/纳米策略。
Nutrients. 2023 Sep 26;15(19):4152. doi: 10.3390/nu15194152.
10
Regulation of Dietary Supplements and Nutraceutical Products in the United States: An Argument for Greater Oversight and Uniform Standards.美国膳食补充剂和营养保健品的监管：加强监管和统一标准的理由
J Clin Pharmacol. 2022 Jan;62(1):14-16. doi: 10.1002/jcph.1982. Epub 2021 Nov 30.
本文引用的文献
1
Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice.口服补充磷脂酰胆碱可减轻饮食诱导的代谢功能障碍相关脂肪性肝炎在雌性 C57BL/6J 小鼠中的发生。
Cell Mol Gastroenterol Hepatol. 2024;17(5):785-800. doi: 10.1016/j.jcmgh.2024.01.009. Epub 2024 Jan 21.
2
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.磷脂酰胆碱作为辅助治疗在改善非酒精性脂肪性肝病和代谢合并症患者肝功能试验中的有效性：来自俄罗斯的真实观察性研究。
BMJ Open Gastroenterol. 2020 Mar 26;7(1):e000368. doi: 10.1136/bmjgast-2019-000368. eCollection 2020.
3
Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.外源性补充磷脂酰胆碱可改善肠道对艰难梭菌毒素的屏障防御功能。
J Trauma Acute Care Surg. 2014 Oct;77(4):570-5; discussion 576. doi: 10.1097/TA.0000000000000378.
4
Mucosal protection by phosphatidylcholine.磷脂酰胆碱的黏膜保护作用。
Dig Dis. 2012;30 Suppl 3:85-91. doi: 10.1159/000342729. Epub 2013 Jan 3.
5
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.核受体依赖性磷脂酰胆碱途径具有抗糖尿病作用。
Nature. 2011 May 25;474(7352):506-10. doi: 10.1038/nature10111.
6
Structural basis for the activation of PPARgamma by oxidized fatty acids.氧化脂肪酸激活过氧化物酶体增殖物激活受体γ的结构基础。
Nat Struct Mol Biol. 2008 Sep;15(9):924-31. doi: 10.1038/nsmb.1474.
7
A lipidomic analysis of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学分析
Hepatology. 2007 Oct;46(4):1081-90. doi: 10.1002/hep.21763.
Zotero 插件